Particle.news
Download on the App Store

Imane Khelif Details Hormone Treatment and SRY Gene, Vows to Meet Tests for LA 2028

She rebukes political uses of her case, highlighting a pending CAS appeal.

Overview

  • In new interviews, the Paris 2024 welterweight champion said she took hormone treatment to lower testosterone before the Games and reduced it to zero for the Dakar qualifier.
  • Khelif stated she carries the SRY gene, reiterated that she is not transgender, and emphasized that she was raised and lives as a woman.
  • She said she is prepared to undergo whatever sex or eligibility tests are required to compete at Los Angeles 2028 and has already sent medical records to World Boxing, noting she has not received a response.
  • Addressing President Donald Trump, she asked not to be used for political agendas and said she aims to fight for another Olympic medal in Los Angeles.
  • She has not competed under World Boxing’s 2025 testing regime and has appealed eligibility standards to the Court of Arbitration for Sport, while a 2025 New Delhi lab report cited in media described a male chromosomal result.